Why does the gut choose apolipoprotein B48 but not B100 for chylomicron formation?

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 294, Issue 1, 2007, Pages

  Lo, Chun Min ^a   Nordskog, Brian K ^a   Nauli, Andromeda M ^a   Zheng, Shuqin ^a   VonLehmden, Sarah B ^a   Yang, Qing ^a   Lee, Dana ^a   Swift, Larry L ^c   Davidson, Nicholas O ^b   Tso, Patrick ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Lymph; Very low density lipoprotein

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CHYLOMICRON; LIPID EMULSION; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; TRIACYLGLYCEROL; TRIOLEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; INTESTINE FUNCTION; KNOCKOUT MOUSE; LIPID ABSORPTION; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ANIMALS; APOLIPOPROTEIN B-100; APOLIPOPROTEIN B-48; APOLIPOPROTEINS A; CARRIER PROTEINS; CHYLOMICRONS; CYTIDINE DEAMINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DUODENUM; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; INTUBATION, GASTROINTESTINAL; LYMPH; LYMPHATIC SYSTEM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; PARTICLE SIZE; TIME FACTORS; TRIOLEIN;

EID: 38349186574     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00123.2007     Document Type: Article

References (39)

1. Athar H, Iqbal J, Jiang XC, Hussain MM. A simple, rapid, and sensitive fluorescence assay for mivrosomal triglyceride transfer protein. J Lipid Res 45: 764-772, 2004.
2. Atzel A, Wetterau JR. Identification of two classes of lipid molecule binding sites on the microsomal triglyceride transfer protein. Biochemistry 33: 15382-15388, 1994.
3. Arbeeny CM, Meyers DS, Bergquist KE, Gregg RE. Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in hamster. J Lipid Res 33: 843-851, 1992.
4. Bollman JL, Cain JC, Grindlay JH. Techniques for the collection of lymph from the liver, small intestine or thoracic duct of the rat. J Lab Clin Med 33: 1349-1352, 1948.
5. Chow SL, Hollander D. A dual, concentration dependent absorption mechanism of linoleic acid by rat jejunum in vitro. J Lipid Res 20: 349-356, 1979.
6. Davidson NO, Drewek MJ, Gordon JI, Elovson J. Rat intestinal apolipoprotein B gene expression. J Clin Invest 82: 300-308, 1988.
7. Davidson NO, Shelness GS. APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation. Annu Rev Nutr 20: 169-193, 2000.
8. Davis RA. Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver. Biochim Biophys Acta 1440: 1-31, 1999.
9. Davis RA, Boogaerts JR. Interhepatic assembly of very low density lipoproteins. Effects of fatty acids on triacylglycerol and lipoprotein synthesis. J Biol Chem 257: 10908-10913, 1982.
10. Dixon JL, Furukawa S, Ginsberg H. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from HepG2 cells by inhibiting early intracellular degradation of apolipoproteins B. J Biol Chem 268: 5080-5086, 1991.
11. Elovson J, Chatterton JE, Bell GT, Schumaker VN, Reuben MA, Puppione DL, Reeve JR Jr, Young NL. Plasma very low density lipoproteins contain a single molecular of apo B lipoprotein. J Lipid Res 29: 1461-1473, 1988.
12. Farese RV Jr, Veniant MM, Cham CM, Flynn LM, Pierotti V, Loring JF, Traber M, Ruland S, Stokowsi RS, Huszar D, Young SG. Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. Proc Natl Acad Sci USA 93: 6393-6398, 1996.
13. Hayashi H, Fujimoto K, Cardelli JA, Nutting DF, Bergstedt S, Tso P. Fat feeding increases size, but not number, of chylomicrons produced by small intestine. Am J Physiol Gastrointest Liver Physiol 259: G709-G719, 1990.
14. Hirano K, Young SG, Farese RV, Ng J, Sande E, Warburton C, Powell-Braxton LM, Davidson NO. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J Biol Chem 271: 9887-9890, 1996.
15. Hoffman CJ, Miller RH, Hultin MB. Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 12: 271-277, 1992.
16. Kendrick JS, Chan L, Higgins JA. Superior role of apolipoprotein B48 over apolipoprotein B100 in chylomicron assembly and fat absorption: an investigation of apobec-1 knock-out and wild-type mice. Biochem J 356: 821-827, 2001.
17. Levy E, Mehran M, Seidman E. Caco-2 cells as a model for intestinal lipoprotein synthesis and secretion. FASEB J 9: 626-635, 1995.
18. Lewis GF, Uffelman K, Naples M, Szeto L, Haidari M, Adeli K. Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster. Endocrinology 146: 247-255, 2005.
19. Lu S, Yao Y, Cheng X, Mitchell S, Leng S, Meng S, Gallagher JW, Shelness GS, Morris G, Mahan J, Frase S, Mansbach CM, Weinberg RB, Black DD. Overexpression of apolipoprotein AIV enhanced lipid secretion in IPEC-1 cells by increasing chylomicron size. J Biol Chem 281: 3473-3483, 2006.
20. Mattson FH, Volpenhein RA. The digestion and absorption of triglycerides. J Biol Chem 239: 2772-2777, 1964.
21. Morrison JR, Pászity C, Stevens ME, Hughes SD, Forte T, Scott J, Rubin EM. Apolipoproteins B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism. Proc Natl Acad Sci USA 93: 7154-7159, 1996.
22. Nakamuta M, Chang BH, Zsigmond E, Kobayashi K, Lei H, Ishida BY, Oka K, Li E, Chan L. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background and restoration of apolipoprotein B mRNA editing by somatic gene transfer of apobec-1. J Biol Chem 271: 25981-25988, 1996.
23. Ockner RK, Hughes FB, Isselbacher KJ K. Very low density lipoproteins in intestinal lymph: role in triglyceride and cholesterol transport during fat absorption. J Clin Invest 48: 2367-2373, 1969.
24. Patsch W, Tamai T, Schonfeld G. Effect of fatty acids on lipid and apoprotein secretion and association in hepatocyte cultures. J Clin Invest 72: 371-378, 1983.15.
25. Phillips ML, Pullinger C, Kroes I, Kroes J, Hardman DA, Chen G, Curtiss LK, Gutierrez MM, Kane JP, Schumaker VN. A single copy of apolipoprotein B-48 is present on the human chylomicron remnant. J Lipid Res 38: 1170-1177, 1997.
26. Small DM. The effects of glyceride structure on absorption and metabolism. Annu Rev Nutr 11: 413-434, 1991.
27. Stremmel W. Uptake of fatty acids by jejunal mucosal cells is mediated by fatty acid binding membrane protein. J Clin Invest 82: 2001-2010, 1988.
28. Swift LL, Jovanovska A, Kakkad B, Ong DE. Microsomal triglyceride transfer protein expression in mouse intestine. Histochem Cell Biol 123: 475-482, 2005.
29. Teng B, Burant CF, Davidson NO. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260: 1816-1819, 1993.
30. Tso P, Balint JA. Formation and transport of chylomicrons by enterocytes to the lymphatics. Am J Physiol Gastrointest Liver Physiol 250: G715-G726, 1986.
31. Tso P, Drake DS, Black DD, Sabesin SM. Evidence for separate pathways of chylomicron and very low-density lipoprotein assembly and transport by rat small intestine. Am J Physiol Gastrointest Liver Physiol 247: G599-G610, 1984.
32. Tso P, Lindström MB, Borgström B. Factors regulating the formation of chylomicrons and very-low-density lipoproteins by the rat small intestine. Biochim Biophys Acta 922: 304-313, 1987.11.
33. Tso P, Pitts V, Granger DN. Role of lymph flow in intestinal chylomicron transport. Am J Physiol Gastrointest Liver Physiol 249: G21-G28, 1985.
34. Tso P, Ragland JB, Sabesin SM. Isolation and characterization of lipoprotein of density<1.006 g/ml from rat hepatic lymph. J Lipid Res 24: 810-820, 1983.
35. Thomson ABR, Grag ML, Clandinin MT. Intestinal aspects of lipid absorption. Can J Physiol Pharmacol 67: 179-191, 1989.
36. Van Greevenbroek MMJ, de Bruin TWA. Chylomicron synthesis by intestinal cells in vitro and in vivo. Atherosclerosis 141: S9-S16, 1998.
37. Xie Y, Nassir F, Luo J, Buhman K, Davidson NO. Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoprotein. Am J Physiol Gastrointest Liver Physiol 285: G735-G746, 2003.
38. Yao Z, McLeod RS. Synthesis and secretion of hepatic apolipoproteins B-containing lipoproteins. Biochim Biophys Acta 1212: 152-166, 1994.
39. Yao Z, Tran K, McLeod RS. Intracellular degradation of newly synthesized apolipoprotein B. J Lipid Res 38: 1937-1953, 1997.